BATOPROTAFIB

ID: ALA4650521

Cas Number: 1801765-04-7

PubChem CID: 118238370

Product Number: T414310, Order Now?

Max Phase: Phase

Molecular Formula: C18H24ClN7OS

Molecular Weight: 421.96

Molecule Type: Small molecule

In stock!

Associated Items:

Names and Identifiers

Synonyms: Batoprotafib | Ptpn11 inhibitor tno155 | Shp2 inhibitor tno155 | Tno 155 | Tno-155 | Tno155 | TNO-155 | TNO155 | TNO155|1801765-04-7|batoprotafib|FPJWORQEGI|TNO-155|SHP2 inhibitor TNO155|PTPN11 inhibitor TNO155|(3S,4S)-8-[6-amino-5-(2-amino-3-chloropyridin-4-yl)sulfanylpyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine|(3S,4S)-8-[6-Amino-5-[(2-amino-3-chloro-4-pyridinyl)thio]-2-pyrazinyl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine|(3S,4S)-8-(6-Amino-5-((2-amino-3-chloropyridin-4-yl)thio)Show More

Canonical SMILES:  C[C@@H]1OCC2(CCN(c3cnc(Sc4ccnc(N)c4Cl)c(N)n3)CC2)[C@@H]1N

Standard InChI:  InChI=1S/C18H24ClN7OS/c1-10-14(20)18(9-27-10)3-6-26(7-4-18)12-8-24-17(16(22)25-12)28-11-2-5-23-15(21)13(11)19/h2,5,8,10,14H,3-4,6-7,9,20H2,1H3,(H2,21,23)(H2,22,25)/t10-,14+/m0/s1

Standard InChI Key:  UCJZOKGUEJUNIO-IINYFYTJSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -2.0774    2.0191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7919    1.6066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7919    0.7816    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0774    0.3691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3630    0.7816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3630    1.6066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6485    0.3691    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0660    0.7816    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0660    1.6066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6485    2.0191    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.7805    0.3690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4950    0.7815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4950    1.6065    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7805    2.0190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0774   -0.4559    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9169    0.7696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2024    0.3571    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2024   -0.4680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9169   -0.8805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6313   -0.4680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6313    0.3571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3850   -0.1324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7176   -1.2884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5245   -1.4599    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9370   -0.7455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7805    2.8440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5565    0.6746    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7575   -0.6593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  2  0
  8  9  2  0
  9 10  1  0
  5  7  1  0
  6 10  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  8 11  1  0
  9 14  1  0
  4 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 16 21  1  0
 23 24  1  0
 24 25  1  0
 22 25  1  0
 22 20  1  0
 20 23  1  0
 14 26  1  0
 12 17  1  0
 22 27  1  6
 25 28  1  6
M  END

Alternative Forms

  1. Parent:

    ALA4650521

    TNO155

Associated Targets(Human)

KYSE-520 cell line (216 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTPN11 Tchem Protein-tyrosine phosphatase 2C (2297 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-468 (9477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK4 Tclin CDK4/Cyclin D3 (681 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK-293T (167025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U2OS (164939 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fibroblast (163371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1D Tchem Casein kinase I delta (4546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2 (9050 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKA Tchem Serine/threonine-protein kinase Aurora-A (10240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR3 Tclin Fibroblast growth factor receptor 3 (7811 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRPF1 Tchem Peregrin (2217 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TRIM24 Tchem Transcription intermediary factor 1-alpha (2087 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Bromodomain-containing protein 4 (13122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

EMT6 (738 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: YesParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: YesAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 421.96Molecular Weight (Monoisotopic): 421.1452AlogP: 2.17#Rotatable Bonds: 3
Polar Surface Area: 129.20Molecular Species: BASEHBA: 9HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.48CX LogP: 1.66CX LogD: -0.38
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.68Np Likeness Score: -0.49

References

1. Unpublished dataset, 
2. LaMarche MJ,Acker M,Argintaru A,Bauer D,Boisclair J,Chan H,Chen CH,Chen YN,Chen Z,Deng Z,Dore M,Dunstan D,Fan J,Fekkes P,Firestone B,Fodor M,Garcia-Fortanet J,Fortin PD,Fridrich C,Giraldes J,Glick M,Grunenfelder D,Hao HX,Hentemann M,Ho S,Jouk A,Kang ZB,Karki R,Kato M,Keen N,Koenig R,LaBonte LR,Larrow J,Liu G,Liu S,Majumdar D,Mathieu S,Meyer MJ,Mohseni M,Ntaganda R,Palermo M,Perez L,Pu M,Ramsey T,Reilly J,Sarver P,Sellers WR,Sendzik M,Shultz MD,Slisz J,Slocum K,Smith T,Spence S,Stams T,Straub C,Tamez V,Toure BB,Towler C,Wang P,Wang H,Williams SL,Yang F,Yu B,Zhang JH,Zhu S.  (2020)  Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer.,  63  (22): [PMID:32910655] [10.1021/acs.jmedchem.0c01170]
3. International Nonproprietary Names for Pharmaceutical Substances (INN), 
4. Tang K, Zhao M, Wu YH, Wu Q, Wang S, Dong Y, Yu B, Song Y, Liu HM..  (2022)  Structure-based design, synthesis and biological evaluation of aminopyrazines as highly potent, selective, and cellularly active allosteric SHP2 inhibitors.,  230  [PMID:35063735] [10.1016/j.ejmech.2022.114106]
5. Chen X, Shu C, Li W, Hou Q, Luo G, Yang K, Wu X..  (2022)  Discovery of a Novel Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2) and Cyclin-Dependent Kinase 4 (CDK4) Dual Inhibitor for the Treatment of Triple-Negative Breast Cancer.,  65  (9.0): [PMID:35447031] [10.1021/acs.jmedchem.2c00063]
6. Zhang J, Zhang Y, Qu B, Yang H, Hu S, Dong X..  (2021)  If small molecules immunotherapy comes, can the prime be far behind?,  218  [PMID:33773287] [10.1016/j.ejmech.2021.113356]
7. EUbOPEN.  (2023)  EUbOPEN Chemogenomics Library - IncuCyte,  [10.6019/CHEMBL5303304]
8. EUbOPEN.  (2023)  Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library,  [10.6019/CHEMBL5308504]